Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Hollingsworth

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Chemistry|November 30, 2012
Are companion diagnostics useful?J Carl Barrett, Melanie M Frigault, Simon Hollingsworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Phase I pharmacokinetic and pharmacodynamic dose-escalation study of RG7160 (GA201), the first glycoengineered monoclonal antibody against the epidermal growth factor receptor, in patients with advanced solid tumorsLuis G Paz-Ares, Carlos Gomez-Roca, Jean-Pierre Delord, et al.
British Journal of Cancer|January 4, 2023
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer careMaria Antonietta Cerone, Tara C Mills, Rowena Sharpe, et al.
British Journal of Cancer|January 25, 2023
Correction to: The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer careMaria Antonietta Cerone, Tara C Mills, Rowena Sharpe, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Chemistry|November 30, 2012
Are companion diagnostics useful?J Carl Barrett, Melanie M Frigault, Simon Hollingsworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Phase I pharmacokinetic and pharmacodynamic dose-escalation study of RG7160 (GA201), the first glycoengineered monoclonal antibody against the epidermal growth factor receptor, in patients with advanced solid tumorsLuis G Paz-Ares, Carlos Gomez-Roca, Jean-Pierre Delord, et al.
British Journal of Cancer|January 4, 2023
The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer careMaria Antonietta Cerone, Tara C Mills, Rowena Sharpe, et al.
British Journal of Cancer|January 25, 2023
Correction to: The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer careMaria Antonietta Cerone, Tara C Mills, Rowena Sharpe, et al.
Pageof 1